By Pat Anson, Editor
One of the less publicized provisions in the Centers for Disease Control and Prevention’s opioid prescribing guidelines is a recommendation that doctors stop urine drug testing of patients for tetrahyrdocannabinol (THC), the psychoactive ingredient that causes the “high” for some marijuana users. The guidelines also discourage doctors from dropping patients if marijuana is detected.
Full Article:
http://www.painnewsnetwork.org/stories/2016/3/18/45g7l80k0vufyjyhb06z2ttgxdj3vk